The skeleton: A multi-functional complex organ. The role of key signalling pathways in osteoclast differentiation and in bone resorption

Journal of Endocrinology

Volumn 211, Issue 2, 2011, Pages 131-143

  Mellis, David J ^a   Itzstein, Cecile ^a   Helfrich, Miep H ^a   Crockett, Julie C ^a  

^a UNIVERSITY OF ABERDEEN   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

TRANSCRIPTION FACTOR;

BONE GROWTH; BONE MATRIX; BONE REMODELING; OSTEOCLASTOGENESIS; OSTEOLYSIS; PRIORITY JOURNAL; REVIEW; SKELETON;

ANIMALS; BONE AND BONES; BONE RESORPTION; CARTILAGE; CELL DIFFERENTIATION; HUMANS; MODELS, BIOLOGICAL; OSTEOCLASTS; RANK LIGAND; SIGNAL TRANSDUCTION;

EID: 83455225056     PISSN: 00220795     EISSN: 14796805     Source Type: Journal    
DOI: 10.1530/JOE-11-0212     Document Type: Review

References (142)

1. Adamopoulos IE, Danks L, Itonaga I, Locklin RM, Sabokbar A, Ferguson DJ & Athanasou NA 2006 Stimulation of osteoclast formation by inflammatory synovial fluid. Virchows Archiv 449 69-77.
2. Albagha OM, Visconti MR, Alonso N, Langston AL, Cundy T, Dargie R, Dunlop MG, Fraser WD, Hooper MJ, Isaia G et al. 2010 Genome-wide association study identifies variants at CSF1, OPTN and TNFRSF11A as genetic risk factors for Paget's disease of bone. Nature Genetics 42 520-524.
3. Andersen TL, Soe K, Sondergaard TE, Plesner T & Delaisse JM 2010 Myeloma cell-induced disruption of bone remodelling compartments leads to osteolytic lesions and generation of osteoclast-myeloma hybrid cells. British Journal of Haematology 148 551-561.
4. Armstrong AP, Tometsko ME, Glaccum M, Sutherland CL, Cosman D & Dougall WC 2002 A RANK/TRAF6-dependent signal transduction pathway is essential for osteoclast cytoskeletal organization and resorptive function. Journal of Biological Chemistry 277 44347-44356.
5. Arnett TR 2010 Acidosis, hypoxia and bone. Archives of Biochemistry and Biophysics 503 103-109.
6. Arnett TR, Gibbons DC, Utting JC, Orriss IR, Hoebertz A, Rosendaal M & Meghji S 2003 Hypoxia is a major stimulator of osteoclast formation and bone resorption. Journal of Cellular Physiology 196 2-8.
7. Arron JR, Vologodskaia M, Wong BR, Naramura M, Kim N, Gu H & Choi Y 2001 A positive regulatory role for Cbl family proteins in tumor necrosis factor-related activation-induced cytokine (trance) and CD40L-mediated Akt activation. Journal of Biological Chemistry 276 30011-30017.
8. AsagiriM, Sato K, Usami T, Ochi S, Nishina H, Yoshida H, Morita I, Wagner EF, Mak TW, Serfling E et al. 2005 Autoamplification of NFATc1 expression determines its essential role in bone homeostasis. Journal of Experimental Medicine 202 1261-1269.
9. Bakiri L, Takada Y, Radolf M, Eferl R, Yaniv M, Wagner EF & Matsuo K 2007 Role of heterodimerization of c-Fos and Fra1 proteins in osteoclast differentiation. Bone 40 867-875.
10. Biosse-Duplan M, Stephens S, Lai FPL, OelkersM, Rottner K, Horne WC& Baron R 2011 In osteoclasts, dynamic microtubules and their assoicated protein EB1 control podosomes and bone resorption through cortactin. Bone 48 (Suppl 2) S97.
11. Blair HC, Borysenko CW, Villa A, Schlesinger PH, Kalla SE, Yaroslavskiy BB, Garcia-Palacios V, Oakley JI & Orchard PJ 2004 In vitro differentiation of CD14 cells from osteopetrotic subjects: contrasting phenotypes with TCIRG1, CLCN7, and attachment defects. Journal of Bone and Mineral Research 19 1329-1338.
12. Block MR, Badowski C, Millon-Fremillon A, Bouvard D, Bouin AP, Faurobert E, Gerber-Scokaert D, Planus E & Albiges-Rizo C 2008 Podosome-type adhesions and focal adhesions, so alike yet so different. European Journal of Cell Biology 87 491-506.
13. Caudrillier A, Hurtel-Lemaire AS, Wattel A, Cournarie F, Godin C, Petit L, Petit JP, Terwilliger E, Kamel S, Brown EM et al. 2010 Strontium ranelate decreases receptor activator of nuclear factor-kappa B ligand-induced osteoclastic differentiation in vitro: involvement of the calcium-sensing receptor. Molecular Pharmacology 78 569-576.
14. Chabadel A, Banon-Rodriguez I, Cluet D, Rudkin BB, Wehrle-Haller B, Genot E, Jurdic P, Anton IM & Saltel F 2007 CD44 and beta3 integrin organize two functionally distinct actin-based domains in osteoclasts. Molecular Biology of the Cell 18 4899-4910.
15. Chambers TJ & Moore A 1983 The sensitivity of isolated osteoclasts to morphological transformation by calcitonin. Journal of Clinical Endocrinology and Metabolism 57 819-824.
16. Chellaiah MA & Hruska KA 2003 The integrin alpha(v)beta(3) and CD44 regulate the actions of osteopontin on osteoclast motility. Calcified Tissue International 72 197-205.
17. Chellaiah MA, Soga N, Swanson S, McAllister S, Alvarez U, Wang D, Dowdy SF & Hruska KA 2000 Rho-A is critical for osteoclast podosome organization, motility, and bone resorption. Journal of Biological Chemistry 275 11993-12002.
18. Coxon FP & Taylor A 2008 Vesicular trafficking in osteoclasts. Seminars in Cell and Developmental Biology 19 424-433.
19. Crockett JC, Schutze N, Tosh D, Jatzke S, Duthie A, Jakob F & Rogers MJ 2007 The matricellular protein CYR61 inhibits osteoclastogenesis by a mechanism independent of alphavbeta3 and alphavbeta5. Endocrinology 148 5761-5768.
20. Crockett JC, Mellis DJ, Scott DI & Helfrich MH 2011a New knowledge on critical osteoclast formation and activation pathways from study of rare genetic diseases of osteoclasts: focus on the RANK/RANKL axis. Osteoporosis International 22 1-20.
21. Crockett JC, Rogers MJ, Coxon FP, Hocking LJ & Helfrich MH 2011b Bone remodelling at a glance. Journal of Cell Science 124 991-998.
22. jcs.063032)Dai XM, Ryan GR, Hapel AJ, Dominguez MG, Russell RG, Kapp S, Sylvestre V & Stanley ER 2002 Targeted disruption of the mouse colonystimulating factor 1 receptor gene results in osteopetrosis, mononuclear phagocyte deficiency, increased primitive progenitor cell frequencies, and reproductive defects. Blood 99 111-120.
23. Darnay BG, Ni J, Moore PA & Aggarwal BB 1999 Activation of NF-kappaB by RANK requires tumor necrosis factor receptor-associated factor (TRAF) 6 and NF-kappaB-inducing kinase. Identification of a novel TRAF6 interaction motif. Journal of Biological Chemistry 274 7724-7731.
24. Davies J, Warwick J, Totty N, Philp R, Helfrich M & Horton M 1989 The osteoclast functional antigen, implicated in the regulation of bone resorption, is biochemically related to the vitronectin receptor. Journal of Cell Biology 109 1817-1826.
25. De Corte V, Gettemans J & Vandekerckhove J 1997 Phosphatidylinositol 4,5-bisphosphate specifically stimulates PP60(c-src) catalyzed phosphorylation of gelsolin and related actin-binding proteins. FEBS Letters 401 191-196.
26. DeKoter RP, Walsh JC & Singh H 1998 PU.1 regulates both cytokinedependent proliferation and differentiation of granulocyte/macrophage progenitors. EMBO Journal 17 4456-4468.
27. Destaing O, Saltel F, Geminard JC, Jurdic P & Bard F 2003 Podosomes display actin turnover and dynamic self-organization in osteoclasts expressing actingreen fluorescent protein. Molecular Biology of the Cell 14 407-416.
28. Destaing O, Saltel F, Gilquin B, Chabadel A, Khochbin S, Ory S & Jurdic P 2005 A novel Rho-mDia2-HDAC6 pathway controls podosome patterning through microtubule acetylation in osteoclasts. Journal of Cell Science 118 2901-2911.
29. Destaing O, Sanjay A, Itzstein C, Horne WC, Toomre D, De Camilli P & Baron R 2008 The tyrosine kinase activity of c-Src regulates actin dynamics and organization of podosomes in osteoclasts. Molecular Biology of the Cell 19 394-404.
30. Dougall WC, Glaccum M, Charrier K, Rohrbach K, Brasel K, De Smedt T, Daro E, Smith J, Tometsko ME, Maliszewski CR et al. 1999 RANK is essential for osteoclast and lymph node development. Genes and Development 13 2412-2424.
31. Duong LT, Lakkakorpi PT, Nakamura I, Machwate M, Nagy RM & Rodan GA 1998 PYK2 in osteoclasts is an adhesion kinase, localized in the sealing zone, activated by ligation of alpha(v)beta3 integrin, and phosphorylated by src kinase. Journal of Clinical Investigation 102 881-892.
32. Edwards CM & Mundy GR 2008 Eph receptors and ephrin signaling pathways: a role in bone homeostasis. International Journal of Medical Sciences 5 263-272.
33. Ek-Rylander B & Andersson G 2010 Osteoclast migration on phosphorylated osteopontin is regulated by endogenous tartrate-resistant acid phosphatase. Experimental Cell Research 316 443-451.
34. Everts V, de Vries TJ & Helfrich MH 2009 Osteoclast heterogeneity: lessons from osteopetrosis and inflammatory conditions. Biochimica et Biophysica Acta 1792 757-765.
35. Faccio R, Grano M, Colucci S, Villa A, Giannelli G, Quaranta V & Zallone A 2002 Localization and possible role of two different alpha v beta 3 integrin conformations in resting and resorbing osteoclasts. Journal of Cell Science 115 2919-2929.
36. Faccio R, Teitelbaum SL, Fujikawa K, Chappel J, Zallone A, Tybulewicz VL, Ross FP & SwatW2005 Vav3 regulates osteoclast function and bone mass. Nature Medicine 11 284-290.
37. Felix R, Cecchini MG & Fleisch H 1990a Macrophage colony stimulating factor restores in vivo bone resorption in the op/op osteopetrotic mouse. Endocrinology 127 2592-2594.
38. Felix R, Cecchini MG, HofstetterW, Elford PR, Stutzer A & Fleisch H 1990b Impairment of macrophage colony-stimulating factor production and lack of resident bone marrow macrophages in the osteopetrotic op/op mouse. Journal of Bone and Mineral Research 5 781-789.
39. Franzoso G, Carlson L, Xing L, Poljak L, Shores EW, Brown KD, Leonardi A, Tran T, Boyce BF & Siebenlist U 1997 Requirement for NF-kappaB in osteoclast and B-cell development. Genes and Development 11 3482-3496.
40. Frasa MA, Maximiano FC, Smolarczyk K, Francis RE, Betson ME, Lozano E, Goldenring J, Seabra MC, Rak A, Ahmadian MR et al. 2010 Armus is a Rac1 effector that inactivates Rab7 and regulates E-cadherin degradation. Current Biology 20 198-208.
41. Fromigue O, Hay E, Barbara A, Petrel C, Traiffort E, Ruat M & Marie PJ 2009 Calcium sensing receptor-dependent and receptor-independent activation of osteoblast replication and survival by strontium ranelate. Journal of Cellular and Molecular Medicine 13 2189-2199.
42. Galibert L, Tometsko ME, Anderson DM, Cosman D & Dougall WC 1998 The involvement of multiple tumor necrosis factor receptor (TNFR)-associated factors in the signaling mechanisms of receptor activator of NF-kappaB, a member of the TNFR superfamily. Journal of Biological Chemistry 273 34120-34127.
43. Gil-Henn H, Destaing O, Sims NA, Aoki K, Alles N, Neff L, Sanjay A, Bruzzaniti A, De Camilli P, Baron R et al. 2007 Defective microtubuledependent podosome organization in osteoclasts leads to increased bone density in Pyk2(-/-) mice. Journal of Cell Biology 178 1053-1064.
44. Goodison S, Urquidi V & Tarin D 1999 CD44 cell adhesion molecules. Molecular Pathology 52 189-196.
45. Grigoriadis AE, Wang ZQ, Cecchini MG, HofstetterW, Felix R, Fleisch HA &Wagner EF 1994 c-Fos: a key regulator of osteoclast-macrophage lineage determination and bone remodeling. Science 266 443-448.
46. Grol MW, Panupinthu N, Korcok J, Sims SM & Dixon SJ 2009 Expression, signaling, and function of P2X7 receptors in bone. Purinergic Signalling 5 205-221.
47. Guerrini MM, Sobacchi C, Cassani B, Abinun M, Kilic SS, Pangrazio A, Moratto D, Mazzolari E, Clayton-Smith J, Orchard P et al. 2008 Human osteoclast-poor osteopetrosis with hypogammaglobulinemia due to TNFRSF11A (RANK) mutations. American Journal of Human Genetics 83 64-76.
48. Hattersley G & Chambers TJ 1991 Calcitonin receptors as markers for osteoclastic differentation: correlation between generation of bone resorptive cells and cells that express calcitonin receptors in mouse bone marrow cultures. Endocrinology 128 1606-1612.
49. Helfrich MH, Mieremet RHP & Thesingh CW 1989 Osteoclast formation in vitro from progenitor cells present in the adult mouse circulation. Journal of Bone and Mineral Research 4 325-334.
50. Higgs HN & Pollard TD 2001 Regulation of actin filament network formation through ARP2/3 complex: activation by a diverse array of proteins. Annual Review of Biochemistry 70 649-676.
51. Hoebertz A, Meghji S, Burnstock G & Arnett TR 2001 Extracellular ADP is a powerful osteolytic agent: evidence for signaling through the P2Y(1) receptor on bone cells. FASEB Journal 15 1139-1148.
52. Horne WC, Sanjay A, Bruzzaniti A & Baron R 2005 The role(s) of Src kinase and Cbl proteins in the regulation of osteoclast differentiation and function. Immunological Reviews 208 106-125.
53. Hsu H, Lacey DL, Dunstan CR, Solovyev I, Colombero A, Timms E, Tan HL, Elliott G, Kelley MJ, Sarosi I et al. 1999 Tumor necrosis factor receptor family member RANK mediates osteoclast differentiation and activation induced by osteoprotegerin ligand. PNAS 96 3540-3545.
54. Hu R, Sharma SM, Bronisz A, Srinivasan R, Sankar U & Ostrowski MC 2007 Eos, MITF, and PU.1 recruit corepressors to osteoclast-specific genes in committed myeloid progenitors. Molecular and Cellular Biology 27 4018-4027.
55. Hughes DE, Dai A, Tiffee JC, Li HH, Mundy GR & Boyce BF 1996 Estrogen promotes apoptosis of murine osteoclasts mediated by TGF-beta. Nature Medicine 2 1132-1136.
56. Humphries JD, Byron A & Humphries MJ 2006 Integrin ligands at a glance. Journal of Cell Science 119 3901-3903.
57. Hurtel-Lemaire AS, Mentaverri R, Caudrillier A, Cournarie F, Wattel A, Kamel S, Terwilliger EF, Brown EM & Brazier M 2009 The calciumsensing receptor is involved in strontium ranelate-induced osteoclast apoptosis. New insights into the associated signaling pathways. Journal of Biological Chemistry 284 575-584.
58. Inzerillo AM, Zaidi M & Huang CL 2002 Calcitonin: the other thyroid hormone. Thyroid 12 791-798.
59. Iotsova V, Caamano J, Loy J, Yang Y, Lewin A & Bravo R 1997 Osteopetrosis in mice lacking NF-kappaB1 and NF-kappaB2. Nature Medicine 3 1285-1289.
60. Ishii J, Kitazawa R, Mori K, McHugh KP, Morii E, Kondo T & Kitazawa S 2008 Lipopolysaccharide suppresses RANK gene expression in macrophages by down-regulating PU.1 and MITF. Journal of Cellular Biochemistry 105 896-904.
61. Itzstein C, Coxon FP & Rogers MJ 2011 The regulation of osteoclast function and bone resorption by small GTPases. Small GTPases 2 117-130.
62. Jurdic P, Saltel F, Chabadel A & Destaing O 2006 Podosome and sealing zone: specificity of the osteoclast model. European Journal of Cell Biology 85 195-202.
63. Kanis JA, Johansson H, Oden A & McCloskey EV 2011 A meta-analysis of the effect of strontium ranelate on the risk of vertebral and non-vertebral fracture in postmenopausal osteoporosis and the interaction with FRAX((R)). Osteoporosis International 22 2347-2355.
64. Kiel DP, Demissie S, Dupuis J, Lunetta KL, Murabito JM & Karasik D 2007 Genome-wide association with bone mass and geometry in the Framingham Heart Study. BMC Medical Genetics 8 (Suppl 1) S14.
65. Kim K, Kim JH, Lee J, Jin HM, Lee SH, Fisher DE, Kook H, Kim KK, Choi Y & Kim N 2005 Nuclear factor of activated T cells c1 induces osteoclastassociated receptor gene expression during tumor necrosis factor-related activation-induced cytokine-mediated osteoclastogenesis. Journal of Biological Chemistry 280 35209-35216.
66. Kim K, Kim JH, Lee J, Jin HM, Kook H, Kim KK, Lee SY & Kim N 2007 MafB negatively regulates RANKL-mediated osteoclast differentiation. Blood 109 3253-3259.
67. Kong YY, Yoshida H, Sarosi I, Tan HL, Timms E, Capparelli C, Morony S, Oliveira-dos-Santos AJ, Van G, Itie A et al. 1999 OPGL is a key regulator of osteoclastogenesis, lymphocyte development and lymph-node organogenesis. Nature 397 315-323.
68. Krum SA & Brown M 2008 Unraveling estrogen action in osteoporosis. Cell Cycle 7 1348-1352.
69. Kwon OH, Lee CK, Lee YI, Paik SG & Lee HJ 2005 The hematopoietic transcription factor PU.1 regulates RANK gene expression in myeloid progenitors. Biochemical and Biophysical Research Communications 335 437-446.
70. Lagasse E & Weissman IL 1997 Enforced expression of Bcl-2 in monocytes rescues macrophages and partially reverses osteopetrosis in op/op mice. Cell 89 1021-1031.
71. Lakkakorpi PT & Väänänen HK 1996 Cytoskeletal changes in osteoclasts during the resorption cycle. Microscopy Research and Technique 33 171-181.
72. Lee ZH & Kim HH 2003 Signal transduction by receptor activator of nuclear factor kappa B in osteoclasts. Biochemical and Biophysical Research Communications 305 211-214.
73. Lomaga MA, Yeh WC, Sarosi I, Duncan GS, Furlonger C, Ho A, Morony S, Capparelli C, Van G, Kaufman S et al. 1999 TRAF6 deficiency results in osteopetrosis and defective interleukin-1, CD40, and LPS signaling. Genes and Development 13 1015-1024.
74. Lorget F, Kamel S, Mentaverri R, Wattel A, NaassilaM, Maamer M& Brazier M 2000 High extracellular calcium concentrations directly stimulate osteoclast apoptosis. Biochemical and Biophysical Research Communications 268 899-903.
75. Lu SY, Li M & Lin YL 2010 Mitf induction by RANKL is critical for osteoclastogenesis. Molecular Biology of the Cell 21 1763-1771.
76. Luchin A, Purdom G, Murphy K, ClarkMY, Angel N, Cassady AI, Hume DA & Ostrowski MC 2000 The microphthalmia transcription factor regulates expression of the tartrate-resistant acid phosphatase gene during terminal differentiation of osteoclasts. Journal of Bone and Mineral Research 15 451-460.
77. Luchin A, Suchting S, Merson T, Rosol TJ, Hume DA, Cassady AI & Ostrowski MC 2001 Genetic and physical interactions between microphthalmia transcription factor and PU.1 are necessary for osteoclast gene expression and differentiation. Journal of Biological Chemistry 276 36703-36710.
78. Luxenburg C, Parsons JT, Addadi L & Geiger B 2006 Involvement of the Srccortactin pathway in podosome formation and turnover during polarization of cultured osteoclasts. Journal of Cell Science 119 4878-4888.
79. Luxenburg C, Geblinger D, Klein E, Anderson K, Hanein D, Geiger B & Addadi L 2007 The architecture of the adhesive apparatus of cultured osteoclasts: from podosome formation to sealing zone assembly. PLoS ONE 2 e179.
80. Marzia M, Chiusaroli R, Neff L, Kim NY, Chishti AH, Baron R & Horne WC 2006 Calpain is required for normal osteoclast function and is downregulated by calcitonin. Journal of Biological Chemistry 281 9745-9754.
81. Matsumoto M, Kogawa M, Wada S, Takayanagi H, TsujimotoM, Katayama S, Hisatake K & Nogi Y 2004 Essential role of p38 mitogen-activated protein kinase in cathepsin K gene expression during osteoclastogenesis through association of NFATc1 and PU.1. Journal of Biological Chemistry 279 45969-45979.
82. McGill GG, Horstmann M, Widlund HR, Du J, Motyckova G, Nishimura EK, Lin YL, Ramaswamy S, AveryW, Ding HF et al. 2002 Bcl2 regulation by the melanocyte master regulator Mitf modulates lineage survival and melanoma cell viability. Cell 109 707-718.
83. McHugh KP, Hodivala-Dilke K, Zheng MH, Namba N, Lam J, Novack D, Feng X, Ross FP, Hynes RO & Teitelbaum SL 2000 Mice lacking beta3 integrins are osteosclerotic because of dysfunctional osteoclasts. Journal of Clinical Investigation 105 433-440.
84. Miyauchi A, Hruska KA, Greenfield EM, Duncan R, Alvarez J, Barattolo R, Colucci S, Zamboninzallone A, Teitelbaum SL & Teti A 1990 Osteoclast cytosolic calcium, regulated by voltage-gated calcium channels and extracellular calcium, controls podosome assembly and bone-resorption. Journal of Cell Biology 111 2543-2552.
85. Miyazaki T, Sanjay A, Neff L, Tanaka S, Horne WC & Baron R 2004 Src kinase activity is essential for osteoclast function. Journal of Biological Chemistry 279 17660-17666.
86. Moser M, Nieswandt B, Ussar S, Pozgajova M & Fassler R 2008 Kindlin-3 is essential for integrin activation and platelet aggregation. Nature Medicine 14 325-330.
87. Motyckova G, Weilbaecher KN, Horstmann M, Rieman DJ, Fisher DZ & Fisher DE 2001 Linking osteopetrosis and pycnodysostosis: regulation of cathepsin K expression by the microphthalmia transcription factor family. PNAS 98 5798-5803.
88. Mulari M, Vaaraniemi J & Väänänen HK 2003a Intracellular membrane trafficking in bone resorbing osteoclasts. Microscopy Research and Technique 61 496-503.
89. Mulari MT, Zhao H, Lakkakorpi PT & Väänänen HK 2003b Osteoclast ruffled border has distinct subdomains for secretion and degraded matrix uptake. Traffic 4 113-125.
90. Murphy HM 1973 The osteopetrotic syndrome in the microphthalmic mutant mouse. Calcified Tissue Research 13 19-26
91. Nakamura I, Pilkington MF, Lakkakorpi PT, Lipfert L, Sims SM, Dixon SJ, Rodan GA & Duong LT 1999 Role of alpha(v)beta(3) integrin in osteoclast migration and formation of the sealing zone. Journal of Cell Science 112 3985-3993.
92. Nishida T, Emura K, Kubota S, Lyons KM & Takigawa M 2011 CCN family 2/connective tissue growth factor (CCN2/CTGF) promotes osteoclastogenesis via induction of and interaction with dendritic cell-specific transmembrane protein (DC-STAMP). Journal of Bone and Mineral Research 26 351-363.
93. Nozawa K, Fujishiro M, Kawasaki M, Kaneko H, Iwabuchi K, Yanagida M, Suzuki F, Miyazawa K, Takasaki Y, Ogawa H et al. 2009 Connective tissue growth factor promotes articular damage by increased osteoclastogenesis in patients with rheumatoid arthritis. Arthritis Research & Therapy 11 R174.
94. Ochotny N, Flenniken AM, Owen C, Voronov I, Zirngibl RA, Osborne LR, Henderson JE, Adamson SL, Rossant J, Manolson MF et al. 2011 The V-ATPase a3 subunit mutation R740S is dominant negative and results in osteopetrosis in mice. Journal of Bone and Mineral Research 26 1484-1493.
95. Orriss IR, Burnstock G & Arnett TR 2010 Purinergic signalling and bone remodelling. Current Opinion in Pharmacology 10 322-330.
96. Orriss I, Syberg S, Wang N, Robaye B, Gartland A, Jorgensen N, Arnett T & Boeynaems JM 2011a Bone phenotypes of P2 receptor knockout mice. Frontiers in Bioscience 3 1038-1046.
97. Orriss IR, Wang N, Burnstock G, Arnett TR, Gartland A, Robaye B & Boeynaems JM. 2011 The P2Y6 receptor stimulates bone resorption by osteoclasts. Endocrinology 152 3706-3716.
98. Orriss IR, Wang N, Burnstock G, Arnett TR, Gartland A, Robaye B & Boeynaems JM 2011b The P2Y6 receptor stimulates bone resorption by osteoclasts. Endocrinology 152 3706-3716. (doi:10.1210/en.2011-1073) Palokangas H, Mulari M & Vaananen HK 1997 Endocytic pathway from the basal plasma membrane to the ruffled border membrane in bone-resorbing osteoclasts. Journal of Cell Science 110 1767-1780.
99. Pavlos NJ, Xu J, Riedel D, Yeoh JS, Teitelbaum SL, Papadimitriou JM, Jahn R, Ross FP & Zheng MH 2005 Rab3D regulates a novel vesicular trafficking pathway that is required for osteoclastic bone resorption. Molecular and Cellular Biology 25 5253-5269.
100. Perbal B 2004 CCN proteins: multifunctional signalling regulators. Lancet 363 62-64.
101. Purev E, Neff L, Horne WC & Baron R 2009 c-Cbl and Cbl-b act redundantly to protect osteoclasts from apoptosis and to displace HDAC6 from beta-tubulin, stabilizing microtubules and podosomes. Molecular Biology of the Cell 20 4021-4030.
102. Rivadeneira F, Styrkarsdottir U, Estrada K, Halldorsson BV, Hsu YH, Richards JB, Zillikens MC, Kavvoura FK, Amin N, Aulchenko YS et al. 2009 Twenty bone-mineral-density loci identified by large-scale metaanalysis of genome-wide association studies. Nature Genetics 41 1199-1206.
103. Rogers MJ, Crockett JC, Coxon FP & Monkkonen J 2010 Biochemical and molecular mechanisms of action of bisphosphonates. Bone 49 34-41.
104. Saltel F, Destaing O, Bard F, Eichert D & Jurdic P 2004 Apatite-mediated actin dynamics in resorbing osteoclasts. Molecular Biology of the Cell 15 5231-5241.
105. Sanjay A, Houghton A, Neff L, DiDomenico E, Bardelay C, Antoine E, Levy J, Gailit J, Bowtell D, Horne WC et al. 2001 Cbl associates with Pyk2 and Src to regulate Src kinase activity, alpha(v)beta(3) integrin-mediated signaling, cell adhesion, and osteoclast motility. Journal of Cell Biology 152 181-195.
106. Schmidt S, Nakchbandi I, Ruppert R, Kawelke N, Hess MW, Pfaller K, Jurdic P, Fassler R & Moser M 2011 Kindlin-3-mediated signaling from multiple integrin classes is required for osteoclast-mediated bone resorption. Journal of Cell Biology 192 883-897.
107. Scott EW, Simon MC, Anastasi J & Singh H 1994 Requirement of transcription factor PU.1 in the development of multiple hematopoietic lineages. Science 265 1573-1577.
108. Sharma SM, Bronisz A, Hu R, Patel K, Mansky KC, Sif S & Ostrowski MC 2007 MITF and PU.1 recruit p38 MAPK and NFATc1 to target genes during osteoclast differentiation. Journal of Biological Chemistry 282 15921-15929.
109. Sharma SM, Sif S, Ostrowski MC & Sankar U 2009 Defective co-activator recruitment in osteoclasts from microphthalmia-oak ridge mutant mice. Journal of Cellular Physiology 220 230-237.
110. Simonet WS, Lacey DL, Dunstan CR, Kelley M, Chang MS, Luthy R, Nguyen HQ, Wooden S, Bennett L, Boone T. et al. 1997 Osteoprotegerin: a novel secreted protein involved in the regulation of bone density. Cell 89 309-319.
111. Sims NA & Gooi JH 2008 Bone remodeling: multiple cellular interactions required for coupling of bone formation and resorption. Seminars in Cell and Developmental Biology 19 444-451.
112. Smink JJ, Begay V, Schoenmaker T, Sterneck E, de Vries TJ & Leutz A 2009 Transcription factor C/EBPbeta isoform ratio regulates osteoclastogenesis through MafB. EMBO Journal 28 1769-1781.
113. Sobacchi C, Frattini A, Guerrini MM, Abinun M, Pangrazio A, Susani L, Bredius R, Mancini G, Cant A, Bishop N et al. 2007 Osteoclast-poor human osteopetrosis due to mutations in the gene encoding RANKL. Nature Genetics 39 960-962.
114. Spinardi L & Marchisio PC 2006 Podosomes as smart regulators of cellular adhesion. European Journal of Cell Biology 85 191-194.
115. Sun Y, Buki KG, Ettala O, Vääraniemi JP & Väänänen HK 2005 Possible role of direct Rac1-Rab7 interaction in ruffled border formation of osteoclasts. Journal of Biological Chemistry 280 32356-32361.
116. Ta HM, Nguyen GT, Jin HM, Choi J, Park H, Kim N, Hwang HY & Kim KK 2010 Structure-based development of a receptor activator of nuclear factor-kappaB ligand (RANKL) inhibitor peptide and molecular basis for osteopetrosis. PNAS 107 20281-20286.
117. Takahashi N, Muto A, Arai A & Mizoguchi T 2010 Identification of cell cycle-arrested quiescent osteoclast precursors in vivo. Advances in Experimental Medicine and Biology 658 21-30.
118. Takayanagi H 2009 Osteoimmunology and the effects of the immune system on bone. Nature Reviews. Rheumatology 5 667-676.
119. Takayanagi H, Kim S, Koga T, Nishina H, Isshiki M, Yoshida H, Saiura A, Isobe M, Yokochi T, Inoue J et al. 2002 Induction and activation of the transcription factor NFATc1 (NFAT2) integrate RANKL signaling in terminal differentiation of osteoclasts. Developmental Cell 3 889-901.
120. Tehrani S, Faccio R, Chandrasekar I, Ross FP & Cooper JA 2006 Cortactin has an essential and specific role in osteoclast actin assembly. Molecular Biology of the Cell 17 2882-2895.
121. Tehrani S, Tomasevic N, Weed S, Sakowicz R & Cooper JA 2007 Src phosphorylation of cortactin enhances actin assembly. PNAS 104 11933-11938.
122. Teitelbaum S & Zou W 2011 The osteoclast cytoskeleton: how does it work? IBMS Bonekey 8 74-83
123. Thesingh CW 1986 Formation sites and distribution of osteoclast progenitor cells during the ontogeny of the mouse. Developmental Biology 117 127-134.
124. Thesingh CW & Scherft JP 1985 Fusion disability of embryonic osteoclast precursor cells and macrophages in the microphthalmic osteopetrotic mouse. Bone 6 43-52.
125. Tondravi MM, McKercher SR, Anderson K, Erdmann JM, Quiroz M, Maki R & Teitelbaum SL 1997 Osteopetrosis in mice lacking haematopoietic transcription factor PU.1. Nature 386 81-84.
126. Van Wesenbeeck L, Odgren PR, Coxon FP, Frattini A, Moens P, Perdu B, MacKay CA, Van Hul E, Timmermans JP, Vanhoenacker F et al. 2007 Involvement of PLEKHM1 in osteoclastic vesicular transport and osteopetrosis in incisors absent rats and humans. Journal of Clinical Investigation 117 919-930. (doi:10.1172/JCI30328)
127. Villa A, Guerrini MM, Cassani B, Pangrazio A & Sobacchi C 2009 Infantile malignant, autosomal recessive osteopetrosis: the rich and the poor. Calcified Tissue International 84 1-12.
128. Wagner EF & Eferl R 2005 Fos/AP-1 proteins in bone and the immune system. Immunological Reviews 208 126-140.
129. Wang C, Deng L, Hong M, Akkaraju GR, Inoue J & Chen ZJ 2001 TAK1 is a ubiquitin-dependent kinase of MKK and IKK. Nature 412 346-351.
130. Weaver AM, Karginov AV, Kinley AW, Weed SA, Li Y, Parsons JT & Cooper JA 2001 Cortactin promotes and stabilizes Arp2/3-induced actin filament network formation. Current Biology 11 370-374.
131. Whyte MP, Obrecht SE, Finnegan PM, Jones JL, Podgornik MN, McAlister WH & Mumm S 2002 Osteoprotegerin deficiency and juvenile Paget's disease. New England Journal of Medicine 347 175-184.
132. Wojtowicz A, Dziedzic-Goclawska A, Kaminski A, StachowiczW, Wojtowicz K, Marks SC Jr & Yamauchi M 1997 Alteration of mineral crystallinity and collagen cross-linking of bones in osteopetrotic toothless (tl/tl) rats and their improvement after treatment with colony stimulating factor-1. Bone 20 127-132.
133. Yaroslavskiy BB, Zhang Y, Kalla SE, Garcia PV, Sharrow AC, Li Y, Zaidi M, Wu C & Blair HC 2005 NO-dependent osteoclast motility: reliance on cGMP-dependent protein kinase I and VASP. Journal of Cell Science 118 5479-5487.
134. Yaroslavskiy BB, Sharrow AC, Wells A, Robinson LJ & Blair HC 2007 Necessity of inositol (1,4,5)-trisphosphate receptor 1 and mu-calpain in NO-induced osteoclast motility. Journal of Cell Science 120 2884-2894.
135. Yoshida H, Hayashi S, Kunisada T, Ogawa M, Nishikawa S, Okamura H, Sudo T & Shultz LD 1990 The murine mutation osteopetrosis is in the coding region of the macrophage colony stimulating factor gene. Nature 345 442-444.
136. Zaidi M, Moonga BS & Huang CL 2004 Calcium sensing and cell signaling processes in the local regulation of osteoclastic bone resorption. Biological Reviews of the Cambridge Philosophical Society 79 79-100.
137. Zhang L, Guo YF, Liu YZ, Liu YJ, Xiong DH, Liu XG, Wang L, Yang TL, Lei SF, Guo Y. et al. 2010 Pathway-based genome-wide association analysis identified the importance of regulation-of-autophagy pathway for ultradistal radius BMD. Journal of Bone and Mineral Research 25 1572-1580.
138. Zhao H, Laitala-Leinonen T, Parikka V & Väänänen HK 2001 Downregulation of small gtpase rab7 impairs osteoclast polarization and bone resorption. Journal of Biological Chemistry 276 39295-39302.
139. Zhao H, Ito Y, Chappel J, Andrews NW, Teitelbaum SL & Ross FP 2008 Synaptotagmin VII regulates bone remodeling by modulating osteoclast and osteoblast secretion. Developmental Cell 14 914-925.
140. Zou W & Teitelbaum SL 2010 Integrins, growth factors, and the osteoclast cytoskeleton. Annals of the New York Academy of Sciences 1192 27-31.
141. ZouW, Kitaura H, Reeve J, Long F, Tybulewicz VL, Shattil SJ, Ginsberg MH, Ross FP & Teitelbaum SL 2007 Syk, c-Src, the alphavbeta3 integrin, and ITAM immunoreceptors, in concert, regulate osteoclastic bone resorption. Journal of Cell Biology 176 877-888.
142. Zuo J, Jiang J, Chen SH, Vergara S, Gong Y, Xue J, Huang H, Kaku M & Holliday LS 2006 Actin binding activity of subunit B of vacuolar HCATPase is involved in its targeting to ruffled membranes of osteoclasts. Journal of Bone and Mineral Research 21 714-721.